Tempo Therapeutics, Inc.
Tempo Therapeutics is a biotechnology and tissue engineering company based out of San Diego, CA specializing in speeding up patient recovery.
Funding history
About Tempo Therapeutics, Inc.
How much funding has Tempo Therapeutics, Inc. raised?
Tempo Therapeutics, Inc. has raised $16.3M in total funding. The most recent round was Series A.
Where is Tempo Therapeutics, Inc. headquartered?
Tempo Therapeutics, Inc. is headquartered in San Diego, CA.
What does Tempo Therapeutics, Inc. do?
Tempo Therapeutics is a biotechnology and tissue engineering company based out of San Diego, CA specializing in speeding up patient recovery.
What problem does Tempo Therapeutics, Inc. solve?
Patients undergoing soft tissue reconstruction for dermal and abdominal wall indications face significant clinical challenges in surgical oncology.
What's Tempo Therapeutics, Inc.'s solution?
Tempo builds functional tissue and organs directly within patients using its MAP (microporous annealed particle) technology, combining immunomodulation and material science to improve tissue strength and restore function.
What makes Tempo Therapeutics, Inc. different?
Their proprietary MAP core technology is also being extended beyond wound repair into combination drug delivery, allogenic cell engraftment, and next-generation vaccine technologies, developed with academic partner labs (the Griffin Lab and Segura Lab).
What makes Tempo Therapeutics, Inc. notable?
Tempo Therapeutics, a San Diego tissue-engineering biotech founded by Westbrook Weaver and Donald Griffin, closed a Series A co-led by Johnson & Johnson Innovation and Galaxy-Sirius Partners.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.